Product Information
TRIJARDY XR 10-5-1,000 MG TAB is a brand product labeled by Boehringer Ingelheim Pharmaceuticals Inc., priced at $11.2864 per EA under NDC 00597038068. Its NADAC has been published 240 times since Jan 19, 2022.
FDA first approved this application on Jan 27, 2020.
Strength
10; 5; 1000 mg/1; mg/1; mg/1
Manufacturer
Boehringer Ingelheim Pharmaceuticals Inc.NDC
00597038068
Classification
Brand
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
EMPAGLIFLOZIN; LINAGLIPTIN; METFORMIN HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA212614FDA Approved
1/27/2020
On Market Since
4/23/2020
Pharmacological Classes
Price Statistics
The NADAC for TRIJARDY XR 10-5-1,000 MG TAB has been published 240 times since Jan 19, 2022, and over the history we have for it it has declined 38.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $11.2864 per EA |
|---|---|
| All-time high | $20.2584 (Dec 31, 2025) |
| All-time low | $11.2355 (May 20, 2026) |
| 52-week high | $20.2584 |
| 52-week low | $11.2355 |
| Median price | $18.9461 |
| Average price | $18.1559 |
| Largest weekly change | -44.4% (Jan 7, 2026) |
| Weeks tracked | 240 |
| Tracking since | Jan 19, 2022 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of TRIJARDY XR 10-5-1,000 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for TRIJARDY XR 10-5-1,000 MG TAB, manufactured by Boehringer Ingelheim Pharmaceuticals Inc., is $11.2864 per EA (NDC 00597038068), effective Aug 19, 2026.
How has the price of TRIJARDY XR 10-5-1,000 MG TAB changed over time?
Over the history we have for it, the NADAC for TRIJARDY XR 10-5-1,000 MG TAB has declined 38.0%. It has been tracked across 240 weekly CMS publications since Jan 19, 2022.
What are the highest and lowest recorded NADAC prices for TRIJARDY XR 10-5-1,000 MG TAB?
Since Jan 19, 2022, the NADAC for TRIJARDY XR 10-5-1,000 MG TAB has ranged from a low of $11.2355 (May 20, 2026) to a high of $20.2584 (Dec 31, 2025), with a median of $18.9461 per EA.
Are there cheaper alternatives to TRIJARDY XR 10-5-1,000 MG TAB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TRIJARDY XR 10-5-1,000 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures TRIJARDY XR 10-5-1,000 MG TAB?
TRIJARDY XR 10-5-1,000 MG TAB (NDC 00597038068) is labeled by Boehringer Ingelheim Pharmaceuticals Inc., and CMS classifies it as a brand product.